1 results match your criteria: "the Kaplan Cancer Center of the New York University Medical Center[Affiliation]"
Arch Pathol Lab Med
February 2000
Department of Pathology, Division of Surgical Pathology, the Kaplan Cancer Center of the New York University Medical Center, New York, NY, USA.
Objective: To test the hypothesis that CD44 standard (CD44[s]) and its other variants, CD44v6 and CD44v7-8, might be useful markers of squamous differentiation in epithelial tumors.
Design: We studied expression of CD44(s), CD44v6, and CD44v7-8 using immunohistochemistry in human tumors that had squamous differentiation, glandular differentiation, or both arising in the colon, stomach, esophagus, lung, pancreas, gallbladder, or uterus/cervix, as well as in adjacent nonneoplastic tissues. Formalin-fixed, paraffin-embedded archival tissue specimens of 33 adenosquamous tumors were used.